|
Match
|
Document |
Document Title |
|
|
US20130090301 |
AGENT FOR SUPPRESSING THE FORMATION OF ABNORMAL SKIN CELLS CAUSED BY EXPOSURE TO LIGHT
An object of the present invention is to provide an agent for suppressing the formation of skin cells induced by exposure to light such as ultraviolet light. The object is achieved by using a... |
|
|
US20110311442 |
DIRECT CELLULAR ENERGY DELIVERY SYSTEM
A lipid vesicle comprising a phospholipid which is a stable vesicle former and at least one unstable vesicle forming member, wherein the unstable vesicle forming member is selected from the group... |
|
|
US20120184504 |
"The Use of a PAR-1 Antagonist in Combination with a P2Y12 ADP Receptor Antagonist for Inhibition of Thrombosis"
The treatment and prevention of thrombotic events are provided through co-administration of PAR-1 and the P2Y12 ADP receptor antagonists. Combined inhibition of the PAR-1 and the P2Y12 ADP... |
|
|
US20140336142 |
Method For Treatment Of Macular Degeneration By Modulating P2Y12 or P2X7 Receptors
Provided is a method of treating or preventing age-related macular degeneration (AMD) in a patient subject to, or symptomatic of the disease, wherein the method comprises restoring normal... |
|
|
US20120264708 |
Method For Treatment Of Macular Degeneration By Modulating P2Y12 or P2X7 Receptors
Provided is a method of treating or preventing age-related macular degeneration (AMD) in a patient subject to, or symptomatic of the disease, wherein the method comprises restoring normal... |
|
|
US20110110914 |
METHODS FOR TREATMENT OF ONCOLOGICAL DISORDERS USING EPIMETABOLIC SHIFTERS, MULTIDIMENSIONAL INTRACELLULAR MOLECULES, OR ENVIRONMENTAL INFLUENCERS
Methods and formulations for treating oncological disorders in humans using epimetabolic shifters, multidimensional intracellular molecules or environmental influencers are described. |
|
|
US20110020312 |
METHODS FOR TREATMENT OF METABOLIC DISORDERS USING EPIMETABOLIC SHIFTERS, MULTIDIMENSIONAL INTRACELLULAR MOLECULES, OR ENVIRONMENTAL INFLUENCERS
Methods and formulations for treating metabolic disorders in humans using epimetabolic shifters, multidimensional intracellular molecules or environmental influencers are described. |
|
|
US20110002907 |
Methods, Systems, Compositions And Dosage Forms For Diagnosing And Treating Male Infertility
Methods and systems are provided for diagnosing male infertility relating to inadequate production of phosphatidic acid and are complementary to the routine tests, assessing sperm count, motility,... |
|
|
US20110217262 |
Treatment of Ocular Surface Disorders by Increasing Conjunctival Vascular Permeability
A method of treating an ocular surface disorder in a subject in need of such treatment is provided. The method includes exposing conjunctival tissue of the subject to an effective amount of a... |
|
|
US20110028421 |
Use of alkylphosphocholines in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals
The invention relates to the use of alkylphosphocholines in combination with antimetabolites for the treatment of multiple myeloma, colon cancer or renal cancer. Preferred alkylphosphocholines are... |
|
|
US20150119352 |
DINUCELOSIDE POLYPHOSPHATES FOR THE TREATMENT OF PAIN
The invention provides a dinucleoside polyphosphate analogue, or a pharmaceutically acceptable salt thereof, for use in the inhibition (or down-regulation) of a pain, via a transducing ATP-gated... |
|
|
US20110046083 |
ACTIVATORS OF PYRUVATE KINASE M2 AND METHODS OF TREATING DISEASE
The invention described herein features methods, compositions, and kits for the use of activators of PKM2 for the treatment, prevention, or amelioration of diseases related to PKM2 function,... |
|
|
US20110243854 |
Methods and systems for identifying modulators of longevity
Methods of treating disorders such as neurofibromatosis-1 are provided, including methods in which catalytic antioxidants such as metalloporphyrins are administered. Methods of regulating... |
|
|
US20130052160 |
COMPOUNDS AND USES THEREOF TO INDUCE AN IMMUNOGENIC CANCER CELL DEATH IN A SUBJECT
The present invention relates to the fields of genetics, immunology and medicine. The present invention more specifically relates to in vitro or ex vivo methods for determining the susceptibility... |
|
|
US20110288043 |
MAINTENANCE OF PLATELET INHIBITION DURING ANTIPLATELET THERAPY
A method of treating or preventing a disease or condition in a subject that was previously treated with at least one thienopyhdine is described. The method includes administering to the subject an... |
|
|
US20110257109 |
USE OF DRUGS THAT ACTIVATE P2Y RECEPTORS TO ENHANCE SYNAPTOGENESIS
The present invention encompasses compositions and methods that activate P2Y receptors for the increased production of new synapses in the central nervous system. The formulations of the invention... |
|
|
US20110014204 |
Cancer Chemoprevention Strategy Based on Loss of Imprinting of IGF2
The present invention relates to targets of loss of imprinting (LOI) affected IGF2 gene products in pre-malignant tissues, where methods of inhibiting those targets, including IGFR1, are disclosed... |
|
|
US20140274937 |
METHODS OF TREATING HEMATOLOGIC CANCERS
This disclosure relates to the treatment of hematologic cancers, for example, cancers of the blood, by methods that include administration of EGCG and at least one of a purine nucleoside analog... |
|
|
US20120190638 |
METHODS OF TREATING HEMATOLOGIC CANCERS
This disclosure relates to the treatment of hematologic cancers, for example, cancers of the blood, by methods that include administration of EGCG and at least one of a purine nucleoside analog... |
|
|
US20110059916 |
Methods and Compositions for Inducing Torpor in a Subject
The present invention relates to the discovery the 5′-AMP and analogues thereof can be used to induce a state of torpor or suspended animation in subjects, as exemplified by studies carried out in... |
|
|
US20070099865 |
Treatment of dry eye conditions
The present invention provides a method for treating dry eye condition in an individual comprising administrating to said individual an amount of A3 adenosine receptor (A3AR) agonist, the amount... |
|
|
US20130017171 |
METHODS AND COMPOSITIONS FOR TREATING HEPATITIS C VIRUS
A method and composition for treating a host infected with hepatitis C comprising administering an effective hepatitis C treatment amount of a described 1′, 2′ or 3′-modified nucleoside or a... |
|
|
US20130108605 |
METHOD OF AMELIORATING OXIDATIVE STRESS AND SUPPLEMENTING THE DIET
A method of supplementing a diet and ameliorating oxidative stress in a mammal includes administering a pharmaceutically effective amount of lipid soluble, hydrophobic active compounds having a... |
|
|
US20150025123 |
P2X7, Inhibition Of Epithelial Cancers And Papillomas
The present invention demonstrates that P2X7 receptor induced apoptosis may be specific for cancerous cells. Treatment with the P2X7 ligand BzATP, increased cellular apoptosis with no associated... |
|
|
US20140037576 |
P2X7: Inhibition Of Epithelial Cancers and Papillomas
The present invention demonstrates that P2X7 receptor induced apoptosis may be specific for cancerous cells. Treatment with the P2X7 ligand BzATP, increased cellular apoptosis with no associated... |
|
|
US20140255492 |
FINE DRY PARTICULATE ADENOSINE COMPOSITIONS AND TOPICAL FORMULATIONS INCLUDING THE SAME
Fine dry particulate adenosine compositions suitable for use in topical formulations, as well as methods of making the same, are provided. In the dry particulate adenosine composition, the... |
|
|
US20100311682 |
ANTIMELANCHOLIC MEDICINE PREPARED WITH JUJUBE CAMP MATERIALS
The antimelancholic medicine or health products prepared with jujuba cAMP materials and the preparative method are provided in the present invention. |
|
|
US20150252112 |
Methods for treating and/or limiting development of diabetes
The present invention provides methods for identifying candidate compounds for limiting development of and/or treating diabetes, and methods for limiting development of and/or treating diabetes. |
|
|
US20140080781 |
Composition of HMB and ATP and Methods of Use
The present invention provides a composition comprising HMB and ATP. Methods of administering HMB and ATP to an animal are also described. HMB and ATP are administered to increase power and... |
|
|
US20120114706 |
Endorphin Therapy Compositions and Methods of Use Thereof
Methods and compositions for treating cancer and other disorders by β-endorphin therapy are disclosed. |
|
|
US20130095125 |
PALATINOSE FOR ENHANCING DIETARY SUPPLEMENT AND PHARMACEUTICAL DELIVERY
The present invention is directed to a dietary supplement comprising palatinose or a derivative thereof. The dietary supplement may be a nutritional product, a sports performance product, a weight... |
|
|
US20100016250 |
TOLL-LIKE RECEPTOR 9 AGONISTS
The present invention provides TLR9 agonists comprising, as an active ingredient, a compound represented by formula (I): (wherein a represents 0 or 1; n represents an integer of 0 to 2; m... |
|
|
US20070141182 |
Combination of multiple nonteroidal antiinflammatory drugs and muscle relaxants for local treatment of musculoskeletal pain
This invention relates to pharmaceutical compositions for use in the treatment of pain and inflammation and the treatment of muscle spasms and associated pain, soreness and tightness of muscles in... |
|
|
US20140044690 |
High-Energy Compounds for Use in Alzheimer's and Other Neurodegenerative Diseases
A method of treating or preventing a neurodegenerative disease includes administering an effective amount of a compound to a subject in need thereof. The compound includes a high-energy compound,... |
|
|
US20130123345 |
METHOD OF TREATING A VIRAL INFECTION DYSFUNCTION BY DISRUPTING AN ADENOSINE RECEPTOR PATHWAY
Described herein is a method of treating a viral infection such as an influenza infection, in a subject comprising administering an effective amount of a pharmaceutical composition to disrupt a... |
|
|
US20100322895 |
T CELL DEPLETING COMPOSITIONS USEFUL FOR TREATING CANCER
The presently-disclosed subject matter provides methods and compositions for treating or reducing the risk of recurrence of a cancer in a subject. The methods comprise administering an effective... |
|
|
US20130216596 |
NANOCAPSULES CONTAINING MICROEMULSIONS
Delivery system based on polymeric nanocapsules which contain microemulsions, and their use in the preparation of pharmaceutical, cosmetic and/or alimentary compositions. |
|
|
US20130018011 |
METHOD OF TREATING DENGUE FEVER
The application provides methods for treatment or prophylaxis of dengue virus mediated diseases with compounds of Formula I wherein R1, R2a, R2b, R3, R4, R5 R6, R8a, R9 and R10 are as defined... |
|
|
US20150099716 |
Maintenance of Platelet Inhibition During Antiplatelet Therapy
A method for reducing or maintaining platelet inhibition in a patient by administering cangrelor prior to an invasive procedure is described. The method of this invention can be used for patients... |
|
|
US20150038449 |
Maintenance of Platelet Inhibition During Antiplatelet Therapy
A method for reducing or maintaining platelet inhibition in a patient by administering cangrelor prior to an invasive procedure is described. The method of this invention can be used for patients... |
|
|
US20130324492 |
Maintenance of Platelet Inhibition During Antiplatelet Therapy
A method for reducing or maintaining platelet inhibition in a patient by administering cangrelor prior to an invasive procedure is described. The method of this invention can be used for patients... |
|
|
US20130316968 |
Maintenance of Platelet Inhibition During Antiplatelet Therapy
A method for reducing or maintaining platelet inhibition in a patient by administering cangrelor prior to an invasive procedure is described. The method of this invention can be used for patients... |
|
|
US20130303477 |
Maintenance of Platelet Inhibition During Antiplatelet Therapy
A method for reducing or maintaining platelet inhibition in a patient by administering cangrelor prior to an invasive procedure is described. The method of this invention can be used for patients... |
|
|
US20120141468 |
MAINTENANCE OF PLATELET INHIBITION DURING ANTIPLATELET THERAPY
A method for reducing or maintaining platelet inhibition in a patient by administering cangrelor prior to an invasive procedure is described. The method of this invention can be used for patients... |
|
|
US20130039956 |
USE OF NITROCARBOXYLIC ACIDS FOR THE TREATMENT, DIAGNOSIS AND PROPHYLAXIS OF AGGRESSIVE HEALING PATTERNS
The invention is directed to implants and medical devices having at least one layer which contains at least one nitrocarboxylic acid. These implants and medical devices shall be used for the... |
|
|
US20150231167 |
TREATMENT OF HEMATOLOGICAL NEOPLASMS
Hematological neoplasms resistant to treatment with an ATP-competitive inhibitor of BCR-ABL are treated by administration of N6-benzyladenosine, N6-benzyladenosine-5′-monophosphate, or... |
|
|
US20100129420 |
METHODS AND DEVICES TO ACCELERATE WOUND HEALING IN THORACIC ANASTOMOSIS APPLICATIONS
A long term oxygen therapy system having an oxygen supply directly linked with a patient's lung or lungs may be utilized to more efficiently treat hypoxia caused by chronic obstructive pulmonary... |
|
|
US20100297040 |
Cellular age advantage; nutrient reservoir cosmetic composition
In recent years the demand for cosmetic compositions and cosmetic methods for improving the appearance and condition of skin has grown enormously; consumers are seeking topical skin care products... |
|
|
US20140322193 |
Therapies for Disorders of the Cornea and Conjunctiva
Unexpectedly, disorders of the cornea and conjunctiva are found to be caused or to be exacerbated, at least in part, by extracellular ATP and P2X7 receptor activation. Therapeutic compositions for... |
|
|
US20150209379 |
TREATMENT OF PROSTATE CANCER AND HEMATOLOGIC NEOPLASMS
Prostate cancer and hematological neoplasms are treated by administration of (i) a compound of Formula I: wherein: R1 is —OH or —O—P(O)(OH)2; and R2 is (II) or (III); (ii) N6-benzyladenosine,... |